TNF‐α blockers intervention vs placebo or additional treatment
Rash · children diagnosed with Kawasaki disease
It is very uncertain whether TNF‐α blockers intervention changes adverse effects after treatment initiation: cutaneous reactions (rash) compared with placebo or additional treatment (very low certainty).
1 finding from 1 review
- TNF‐α blockers for the treatment of Kawasaki disease in children 2019 · Cochrane Headline outcomes onlyRR 4.71 [0.24, 90.69]1 study · 31 participantsVery low